C9275 HCPCS code: Injection, hexaminolevulinate hydrochloride, 100 mg, per study dose
C9275 is the HCPCS Level II code for injection, hexaminolevulinate hydrochloride, 100 mg, per study dose. CMS terminated C9275 on 2018-12-31; do not bill it for later dates of service. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met.
Code details
| Field | Value |
|---|---|
| Section | C codes — Outpatient PPS (hospital outpatient temporary codes) |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 53 |
| BETOS category | O1E — Other drugs |
| Added | 2011-01-01 |
| Last action effective | 2019-01-01 |
| Terminated | 2018-12-31 |
What changed for C9275
- 2011-01-01: C9275 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code C9275?
C9275 is the HCPCS Level II code for injection, hexaminolevulinate hydrochloride, 100 mg, per study dose. Short descriptor: "Hexaminolevulinate hcl".
Does Medicare cover C9275?
Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.
Related C92 codes
- C9248 — Injection, clevidipine butyrate, 1 mg
- C9250 — Human plasma fibrin sealant, vapor-heated, solvent-detergent (artiss), 2 ml
- C9254 — Injection, lacosamide, 1 mg
- C9257 — Injection, bevacizumab, 0.25 mg
- C9285 — Lidocaine 70 mg/tetracaine 70 mg, per patch
- C9290 — Injection, bupivacaine liposome, 1 mg
- C9293 — Injection, glucarpidase, 10 units
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under C9275
- Watch C9275 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for C9275
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.